162 related articles for article (PubMed ID: 32140881)
1. IL33 activates CD8+T and NK cells through MyD88 pathway to suppress the lung cancer cell growth in mice.
Xu L; Zheng Y; Wang J; Xu Y; Xie Y; Yang ZP
Biotechnol Lett; 2020 Jul; 42(7):1113-1121. PubMed ID: 32140881
[TBL] [Abstract][Full Text] [Related]
2. Evaluating vaccinia virus cytokine co-expression in TLR GKO mice.
Sutherland DB; Ranasinghe C; Regner M; Phipps S; Matthaei KI; Day SL; Ramshaw IA
Immunol Cell Biol; 2011 Aug; 89(6):706-15. PubMed ID: 21173782
[TBL] [Abstract][Full Text] [Related]
3. Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells.
Gao X; Wang X; Yang Q; Zhao X; Wen W; Li G; Lu J; Qin W; Qi Y; Xie F; Jiang J; Wu C; Zhang X; Chen X; Turnquist H; Zhu Y; Lu B
J Immunol; 2015 Jan; 194(1):438-45. PubMed ID: 25429071
[TBL] [Abstract][Full Text] [Related]
4. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.
Fujii S; Shimizu K; Smith C; Bonifaz L; Steinman RM
J Exp Med; 2003 Jul; 198(2):267-79. PubMed ID: 12874260
[TBL] [Abstract][Full Text] [Related]
5. MyD88-dependent signaling drives host survival and early cytokine production during Histoplasma capsulatum infection.
Coady A; Sil A
Infect Immun; 2015 Apr; 83(4):1265-75. PubMed ID: 25583527
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-induced activation of adaptive and innate antitumor immunity.
van den Broeke LT; Daschbach E; Thomas EK; Andringa G; Berzofsky JA
J Immunol; 2003 Dec; 171(11):5842-52. PubMed ID: 14634094
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation.
Kaisho T; Hoshino K; Iwabe T; Takeuchi O; Yasui T; Akira S
Int Immunol; 2002 Jul; 14(7):695-700. PubMed ID: 12096028
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells, macrophages, NK and CD8
Lucinda N; Figueiredo MM; Pessoa NL; Santos BS; Lima GK; Freitas AM; Machado AM; Kroon EG; Antonelli LR; Campos MA
Virol J; 2017 Feb; 14(1):37. PubMed ID: 28222752
[TBL] [Abstract][Full Text] [Related]
9. Production of IFN-γ by splenic dendritic cells during innate immune responses against Francisella tularensis LVS depends on MyD88, but not TLR2, TLR4, or TLR9.
De Pascalis R; Rossi AP; Mittereder L; Takeda K; Akue A; Kurtz SL; Elkins KL
PLoS One; 2020; 15(8):e0237034. PubMed ID: 32745117
[TBL] [Abstract][Full Text] [Related]
10. Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice.
Gao K; Li X; Zhang L; Bai L; Dong W; Gao K; Shi G; Xia X; Wu L; Zhang L
Cancer Lett; 2013 Jul; 335(2):463-71. PubMed ID: 23499895
[TBL] [Abstract][Full Text] [Related]
11. Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer.
Dominguez D; Ye C; Geng Z; Chen S; Fan J; Qin L; Long A; Wang L; Zhang Z; Zhang Y; Fang D; Kuzel TM; Zhang B
J Immunol; 2017 Feb; 198(3):1365-1375. PubMed ID: 28011934
[TBL] [Abstract][Full Text] [Related]
12. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
13. Enhancing Dendritic Cell-based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors.
Kim MT; Richer MJ; Gross BP; Norian LA; Badovinac VP; Harty JT
J Immunol; 2015 Nov; 195(9):4537-44. PubMed ID: 26408669
[TBL] [Abstract][Full Text] [Related]
14. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
[TBL] [Abstract][Full Text] [Related]
15. MyD88 signaling contributes to early pulmonary responses to Aspergillus fumigatus.
Bretz C; Gersuk G; Knoblaugh S; Chaudhary N; Randolph-Habecker J; Hackman RC; Staab J; Marr KA
Infect Immun; 2008 Mar; 76(3):952-8. PubMed ID: 18039832
[TBL] [Abstract][Full Text] [Related]
16. Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice.
Zhang M; Ju W; Yao Z; Yu P; Wei BR; Simpson RM; Waitz R; Fassò M; Allison JP; Waldmann TA
J Immunol; 2012 Jun; 188(12):6156-64. PubMed ID: 22593619
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cells mature independently of MyD88 and IFN-αβR in response to Listeria and stimulate CD8 T cells.
Tam MA; Wenzel UA; Wick MJ
Immunol Lett; 2011 Aug; 138(2):104-12. PubMed ID: 21453725
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice.
Akao Y; Ebihara T; Masuda H; Saeki Y; Akazawa T; Hazeki K; Hazeki O; Matsumoto M; Seya T
Cancer Sci; 2009 Aug; 100(8):1494-501. PubMed ID: 19432881
[TBL] [Abstract][Full Text] [Related]
19. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
[TBL] [Abstract][Full Text] [Related]
20. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
Dobrzanski MJ; Reome JB; Dutton RW
J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]